Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
43.18
-40.09
-92.84%
Share Warrants & Outstandings
Total Reserve
68.71
44.62
24.09
53.99%
Shareholder's Funds
71.80
87.80
-16.00
-18.22%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.11
-26.82
26.93
100.41%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
6.42
-6.42
-100.00%
Total Non-Current Liabilities
0.11
-20.40
20.51
100.54%
Current Liabilities
Trade Payables
38.70
0.48
38.22
7,962.50%
Other Current Liabilities
0.94
13.72
-12.78
-93.15%
Short Term Borrowings
9.91
70.22
-60.31
-85.89%
Short Term Provisions
0.02
7.02
-7.00
-99.72%
Total Current Liabilities
49.58
91.44
-41.86
-45.78%
Total Liabilities
121.49
158.84
-37.35
-23.51%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
157.12
-140.27
-89.28%
Less: Accumulated Depreciation
6.37
41.79
-35.42
-84.76%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
115.33
-104.85
-90.91%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
0.71
0.04
5.63%
Other Non Current Assets
3.46
9.73
-6.27
-64.44%
Total Non-Current Assets
18.13
125.78
-107.65
-85.59%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
1.43
36.58
2,558.04%
Sundry Debtors
56.54
13.88
42.66
307.35%
Cash and Bank
0.16
8.74
-8.58
-98.17%
Other Current Assets
0.17
1.74
-1.57
-90.23%
Short Term Loans and Advances
8.13
7.28
0.85
11.68%
Total Current Assets
103.36
33.06
70.30
212.64%
Net Current Assets (Including Current Investments)
53.78
-58.38
112.16
192.12%
Total Current Assets Excluding Current Investments
103.00
33.06
69.94
211.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
158.84
-37.35
-23.51%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
70.22
-60.31
-85.89%
Book Value per share (adjusted)
232.39
-5.43
237.82
4,379.74%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






